retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset Mounjaro: Retatrutide and Diabetes -
Description
Long-acting formulations reduce dosing frequency
But the glucagon component adds something Mounjaro cannot: increased energy output
Several factors can increase the likelihood of experiencing GLP-1 hair loss: Rate of weight loss: Faster weight loss places greater stress on the body, increasing the chance of telogen effluvium
Clinical studies have found reductions in both systolic and diastolic blood pressure among patients taking tirzepatide, with much of the benefit occurring alongside significant weight loss
Which symptoms are red flags
Sugar reduction is a hot topic, and it comes with its own set of challenges
